These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4296870)

  • 1. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
    Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on safety tests of inactivated poliomyelitis vaccines. VI. On the effect of cortisone in monkey experiments].
    Günther O; Unterharnscheidt F; Hövel H
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):166-79. PubMed ID: 4967641
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the characteristics of poliovirus type 3. II. Characteristics of "hot" clones.
    Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
    Acta Virol; 1976 Oct; 20(5):366-72. PubMed ID: 63237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The CNS lesion in monkeys spinally infected with the vaccinal poliomyelitis virus].
    Tereshkina NV; Lavrova IK; Kozlov VG; Sobolev SG; Tiufanov AV; Koroleva GA; Grigor'eva LV; Chigirinskiĭ AE
    Vopr Virusol; 1991; 36(3):222-6. PubMed ID: 1654009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of poliovirus type 3 strains after passage through monkey central nervous system.
    Jarzabek ZJ; Sadowski W; Janicki P
    Acta Virol; 1977 Jan; 21(1):57-62. PubMed ID: 15438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains].
    Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952
    [No Abstract]   [Full Text] [Related]  

  • 9. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STUDIES ON TESTS FOR THE NON-TOXICITY OF INACTIVATED POLIOMYELITIS VACCINES. 1. INFLUENCE OF MAGNESIUM CHLORIDE ON THE SUSCEPTIBILITY OF MONKEY KIDNEY CELL CULTURES TO FORMALIN-TREATED POLIOMYELITIS VIRUS].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Nov; 190():313-21. PubMed ID: 14105973
    [No Abstract]   [Full Text] [Related]  

  • 11. International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine.
    Boulger LR; Arya SC; Ahourai P; Marsden SA
    J Biol Stand; 1978 Jul; 6(3):233-42. PubMed ID: 102647
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental poliomyelitis in bonnet monkey. Clinical features, virology and pathology.
    Samuel BU; Ponnuraj E; Rajasingh J; John TJ
    Dev Biol Stand; 1993; 78():71-8. PubMed ID: 8388833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the characteristics of Poliovirus type 3. III. Strain characteristics after passage in man.
    Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
    Acta Virol; 1976 Oct; 20(5):373-9. PubMed ID: 11664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types].
    Unterharnscheidt F; Bonin O; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):1-12. PubMed ID: 4290953
    [No Abstract]   [Full Text] [Related]  

  • 15. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivated vaccines based on alternatives to wild-type seed virus.
    Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
    Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
    [No Abstract]   [Full Text] [Related]  

  • 18. [Several virologic and biochemical aspects of vaccination with antipoliomyelitis vaccine. Fate of the parent virus].
    Kiselev FL; Sadogurskaia EM; Gorshunova LP
    Vopr Virusol; 1977; (2):184-9. PubMed ID: 197713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaps in scientific knowledge for the post eradication world.
    Minor P
    Biologicals; 2006 Jun; 34(2):167-70. PubMed ID: 16678439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.